Medicines shortages

Stock levels sufficient for at least two adrenaline auto-injectors per prescription

Patients presenting with a prescription can now be given at least two adrenaline 150 microgram auto-injectors that are either in date or have a formally extended expiry date, according to a revised interim protocol issued by the Department of Health and Social Care (DHSC).

The revised protocol, , says that while stock levels are now sufficient, supplies may be constrained until the end of 2018 owing to a backlog of patients requiring prescriptions. The existing dispenser and wholesaler prescription validation processes will continue for all adrenaline 150 microgram auto-injector prescriptions.

Pharmacies are being advised to read the DHSC protocol, which also includes a revised flowchart of questions to ask patients aiming to ascertain those who are in most need of supply, and implement the protocol with immediate effect.

The shortage of EpiPens was first highlighted in May 2018 when the UK supplier Mylan identified shortcomings owing to manufacturing problems. Jext and Emerade 0.15mg adrenaline auto-injectors have now also been rapidly depleted as a knock-on effect of supply problems. 

Citation: The Salvadore DOI: 10.1211/PJ.2018.20205708

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Non-prescription Medicines

    Reviews over-the-counter medicines, arranged by the conditions they are licensed to treat. Includes product recommendations.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Jobs you might like

  • Camberley Drive in Liverpool L25 9PU and Mosley Street in Blackburn BB2 3RX

  • London (Central), London (Greater)

  • Warrington, Cheshire

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.